SinoMab Awarded the “Best Small and Mid-Cap Company” and “Best CEO” in the Selection...
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research,...
Clinical Evaluation of LeSoleil Against COVID-19
Announcement on Global Recruitment of Collaborative Agencies for LeSoleil
Since February 2020, when Suntrap Life Technologies Ltd established a COVID-19 project for drug discovery, the...
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
- Former Fresenius-Kabi China President to join Oculis in February 2022 to lead global operations and the company's business in China
- Will be based...
B-cell lymphoma clinical trials now open on the TrialWire Platform
TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform.
More than 6 million people have used TrialWire...
Autism clinical trials now open on the TrialWire Platform
TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform.
More than 6 million people have used TrialWire...
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for...
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Guo-Liang Yu, PhD,...
Sirnaomics Ltd., the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both China and...
Sirnaomics Ltd. ("Sirnaomics" or "Company", together with its subsidiaries, the "Group", stock code: 2257.HK), the RNA therapeutics biopharmaceutical company with strong presence in both...
Sirnaomics Ltd. Announces Proposed Listing on the Main Board of SEHK
Sirnaomics Ltd. ("Sirnaomics" or "Company", stock code: 2257.HK), the RNA therapeutics biopharmaceutical company withs strong presence in both China and the U.S., today announces...
Pharmaron: A Premier R&D Services Provider for the Life Sciences Industry, Dedicated to Innovation...
2021 the 11th Hong Kong International Finance Forum & China Securities Golden Bauhinia Awards Ceremony, themed "The 14th Five-Year, a New Journey", was held...
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100...
Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited ("Q&M...
HMI Group Expands Singapore Presence, Doubles Down on Value-based Care Offering
Health Management International Pte Ltd (HMI Group), a growing regional private healthcare provider with presence in Singapore, Malaysia and Indonesia, is expanding its Singapore...
Biolidics to Commence Commercial Production of its ClearEpi SARS-COV-2 Neutralising Antibody Rapid Test Kit
Biolidics Limited ("Biolidics" or the "Company" and together with its subsidiaries, the "Group"), a medical technology company with a focus on innovative diagnostic solutions,...
Avantor Provides Critical Personal Protection Supplies to Vulnerable Populations through NGOs
Avantor, Inc. a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, today...
Acumen Diagnostics’ PCR capabilities to tackle Omicron COVID-19 variant
Highly accurate, cost-effective, affordable PCR tests with 2 laboratories able to undertake 7000 tests daily
PCR test kits able to detect COVID-19 positive...
Jacobson Pharma Announces FY2022 Interim Results
Robust Growth of 11.6% in Generics Business Amidst the Pandemic
Confident about Sustaining Strong Growth Momentum
Declares Interim Dividend of HK1.2 Cents Per...
Tianda Pharma Interim Results 2021
Significant business growth achieved
R&D efforts and BD initiatives to continue
Tianda Pharmaceuticals Limited (Tianda Pharma or the Group, HKG: 455) is pleased to...
SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health
SinoMab BioScience Limited (SinoMab, or the Company, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics...
Inaugural Asia Summit on Global Health successfully explores healthcare landscape
Event attracts 21,000+ participants, sustainable development and technological innovation in focus
Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and...
Inaugural Asia Summit on Global Health opens today
70+ business leaders and medical experts gather to examine healthcare landscape
Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the...
ACT Genomics and Sanomics Merge to Unleash Hong Kong’s Global Potential in Healthcare Technology
ACT Genomics Holdings Co. Ltd. ("ACT Genomics" or "the Group") a leading cancer solution provider in Asia, announced today that it has merged with...
